CMLSQ · As filed with the SEC
Cumulus Media cash flow statement, by fiscal year
The statement as Cumulus Media presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD thousands
| USD thousands | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | (200,702) | (283,254) | (117,879) | 16,235 |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation and amortization | 54,336 | 59,123 | 58,176 | 56,386 |
| Amortization and write-off of debt issuance costs | — | — | 2,039 | 2,565 |
| Amortization and write-off of debt issuance costs | 1,018 | 1,248 | — | — |
| Amortization of debt discount | (5,904) | (3,660) | — | — |
| Provision for doubtful accounts | 3,898 | 2,495 | 3,164 | 3,411 |
| (Gain) loss on sale of assets or stations | (2,616) | 1,368 | (16,064) | (1,537) |
| Gain on sale of BMI | 0 | (14,846) | — | — |
| Impairment of right-of-use assets | 0 | 2,844 | 11,404 | — |
| Change in fair value of contingent consideration | — | 0 | (2,000) | — |
| Impairment of intangible assets | 109,829 | 224,481 | 65,312 | 15,544 |
| Impairment of assets held for sale | 1,420 | — | — | — |
| Deferred income taxes | (2,325) | (10,000) | 17,644 | 1,037 |
| Stock-based compensation expense | 2,504 | 4,709 | 5,270 | 6,229 |
| Gain on early extinguishment of debt | 0 | (170) | (9,849) | (4,496) |
| Non-cash interest expense on financing liabilities | 2,981 | 4,024 | 3,918 | 3,721 |
| Non-cash imputed rental income | (5,005) | (4,929) | (4,782) | (4,643) |
| Changes in assets and liabilities (excluding acquisitions and dispositions): | ||||
| Accounts receivable | 27,696 | 21,725 | 26,384 | (16,731) |
| Trade receivable | (4,397) | (1,359) | 549 | (146) |
| Prepaid expenses and other current assets | (545) | 5,169 | 1,560 | 5,320 |
| Operating leases | — | — | — | 1,565 |
| Operating leases, net | (2,311) | (1,370) | (2,054) | — |
| Other assets | 222 | (1,261) | (8,640) | (2,081) |
| Accounts payable and accrued expenses | (1,623) | (11,459) | (2,515) | (285) |
| Trade payable | 50 | 278 | (660) | 1,062 |
| Other liabilities | 138 | 1,725 | 684 | (4,676) |
| Net cash used in operating activities | (21,336) | (3,119) | 31,661 | 78,480 |
| Cash flows from investing activities: | ||||
| Proceeds from sale of assets or stations | 12,378 | 56 | 17,814 | 2,011 |
| Asset acquisition | — | — | — | (135) |
| Asset acquisition | — | — | 0 | — |
| Proceeds from sale of BMI | 0 | 14,846 | — | — |
| Proceeds from insurance reimbursement | 0 | 331 | 179 | 2,950 |
| Capital expenditures | (20,237) | (19,464) | (24,814) | (31,062) |
| Net cash used in investing activities | (7,859) | (4,231) | (6,821) | (26,236) |
| Cash flows from financing activities: | ||||
| Repayment of borrowings under Term Loan due 2026 | — | 0 | (7,900) | (17,471) |
| Repayment of borrowings under Senior Notes due 2026 | 0 | (330) | (25,861) | (64,589) |
| Repayments of borrowings under the 2020 revolving credit facility | — | — | — | 0 |
| Proceeds from PPP loans | — | — | — | 0 |
| Treasury stock purchases | — | 0 | (7,788) | (31,856) |
| Payment of contingent consideration | — | 0 | (2,000) | (1,000) |
| Borrowings under the 2020 revolving credit facility | 55,000 | — | — | — |
| Financing costs on Revolving Credit Agreement | 0 | (275) | — | — |
| Shares returned in lieu of tax payments | (274) | (1,086) | (1,426) | (1,700) |
| Transaction costs for financing liability | — | — | — | 0 |
| Proceeds from financing liability | — | — | — | 0 |
| Repayments of financing liabilities | (6,272) | (6,697) | (5,801) | (4,936) |
| Repayments of finance lease obligations | — | — | — | (287) |
| Repayments of finance lease obligations | (1,116) | (1,086) | (837) | — |
| Net cash provided by (used in) financing activities | 47,338 | (9,474) | (51,613) | (121,839) |
| Increase (decrease) in cash and cash equivalents | 18,143 | (16,824) | (26,773) | (69,595) |
| Cash and cash equivalents at beginning of period | 63,836 | 80,660 | 107,433 | 177,028 |
| Cash and cash equivalents at end of period | 81,979 | 63,836 | 80,660 | 107,433 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.